Effects of Erythropoietin on Frataxin Levels and Mitochondrial Function in Friedreich Ataxia – a Dose–Response Trial (Q56974507)

7

0 references

Guenter Weiss

object named as

Guenter Weiss

10

0 references

Werner Poewe

9

object named as

Werner Poewe

0 references

author name string

Wolfgang Nachbauer

1

0 references

Sascha Hering

2

0 references

Markus Seifert

3

0 references

Hannes Steinkellner

4

0 references

Barbara Scheiber-Mojdehkar

6

0 references

Alexander Strasak

8

0 references

Sylvia Boesch

https://scigraph.springernature.com/pub.10.1007/s12311-011-0287-9

11

0 references

publication date

20 May 2011

0 references

published in

The Cerebellum

0 references

volume

10

0 references

issue

4

0 references

page(s)

763-769

0 references

exact match

0 references

cites work

Neurodegenerative disorders associated with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS12311-011-0287-9

Clinical and genetic study of Friedreich ataxia in an Australian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-011-0287-9

Friedreich's ataxia and scoliosis: the experience at two institutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-011-0287-9

Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-011-0287-9

Real time PCR quantification of frataxin mRNA in the peripheral blood leucocytes of Friedreich ataxia patients and carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-011-0287-9

Iron-sulfur cluster biogenesis and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-011-0287-9

Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-011-0287-9

A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-011-0287-9

Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-011-0287-9

Recombinant human erythropoietin: effects on frataxin expression in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-011-0287-9

Neurological effects of recombinant human erythropoietin in Friedreich's ataxia: a clinical pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-011-0287-9

Comparison of three clinical rating scales in Friedreich ataxia (FRDA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-011-0287-9

Scale for the assessment and rating of ataxia: development of a new clinical scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-011-0287-9

A high throughput electrochemiluminescence assay for the quantification of frataxin protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-011-0287-9

Iron-dependent changes in cellular energy metabolism: influence on citric acid cycle and oxidative phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-011-0287-9

Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after single and multiple doses in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-011-0287-9

Anemia of chronic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-011-0287-9

Complex regulation of transferrin receptors during erythropoietin-induced differentiation of J2E erythroid cells--elevated transcription and mRNA stabilisation produce only a modest rise in protein content

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-011-0287-9

Erythropoietin after a century of research: younger than ever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-011-0287-9

Mitochondrial ferritin limits oxidative damage regulating mitochondrial iron availability: hypothesis for a protective role in Friedreich ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-011-0287-9

The ins and outs of mitochondrial iron-loading: the metabolic defect in Friedreich's ataxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12311-011-0287-9

Recent developments in the anemia of chronic disease.

21 January 2018

1 reference

12 December 2020

Erythropoietin titers in health and disease

1 reference

12 December 2020

Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features

1 reference

12 December 2020

Epoetin alfa increases frataxin production in Friedreich's ataxia without affecting hematocrit

1 reference

12 December 2020

Friedreich's ataxia: clinical pilot trial with recombinant human erythropoietin

1 reference

12 December 2020

Regulation of cellular iron metabolism by erythropoietin: activation of iron-regulatory protein and upregulation of transferrin receptor expression in erythroid cells

1 reference

12 December 2020

An enzymatic cycling procedure for NAD+ using an irreversible reaction with NAD+-peroxidase

1 reference

12 December 2020